Dendritic cell vaccination and immune monitoring

被引：0
|
作者：
E. H. J. G. Aarntzen
C. G. Figdor
G. J. Adema
C. J. A. Punt
I. J. M. de Vries
机构：
[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology
[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato
[4] Radboud University Nijmegen Medical Centre,Oncology
[5] Nijmegen Centre for Molecular Life Sciences,undefined
[6] Radboud University Nijmegen Medical Centre,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.
引用
收藏
页码：1559 / 1568
页数：9
相关论文
共 50 条
  • [41] Dendritic cell vaccination for the treatment of skin cancer
    Nestle, FO
    CANCERS OF THE SKIN, PROCEEDINGS, 2002, 160 : 165 - 169
  • [42] Dendritic cell vaccination for hepatocellular carcinoma.
    Midgley, R
    Palmer, D
    Mirza, N
    Steele, J
    Steven, J
    Kerr, DJ
    Young, LS
    Adams, DH
    HEPATOLOGY, 2003, 38 (04) : 280A - 280A
  • [43] Dendritic-cell vaccination for metastatic melanoma?
    Chen, V
    LANCET ONCOLOGY, 2006, 7 (05): : 368 - 368
  • [44] Dendritic cell vaccination in medullary thyroid carcinoma
    Stift, A
    Sachet, M
    Yagubian, R
    Bittermann, C
    Dubsky, P
    Brostjan, C
    Pfragner, R
    Niederle, B
    Jakesz, R
    Gnant, M
    Friedl, J
    CLINICAL CANCER RESEARCH, 2004, 10 (09) : 2944 - 2953
  • [45] Regulating dendritic cell signalling to improve vaccination
    Collins, Mary
    HUMAN GENE THERAPY, 2012, 23 (10) : A14 - A14
  • [46] Dendritic-cell vaccination for prostate cancer
    Thomas-Kaskel, Anna-Katharina
    Veelken, Hendrik
    IMMUNOTHERAPY, 2009, 1 (01) : 63 - 72
  • [47] Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination
    Morteza Samadi-Foroushani
    Rouhollah Vahabpour
    Arash Memarnejadian
    Afshin Namdar
    Masoumeh Khamisabadi
    Seyed Mehdi Sadat
    Hossein Asgarian-Omran
    Kayhan Azadmanesh
    Parviz Kokhaei
    Mohammad Reza Aghasadeghi
    Jamshid Hadjati
    Medical Oncology, 2011, 28 : 660 - 666
  • [48] Erratum: Dendritic cell vaccination for cancer therapy
    Frank O Nestle
    Oncogene, 2001, 20 : 6970 - 6970
  • [49] Regulating dendritic cell signalling to improve vaccination
    Collins, Mary
    HUMAN GENE THERAPY, 2013, 24 (05) : A13 - A13
  • [50] Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination
    Samadi-Foroushani, Morteza
    Vahabpour, Rouhollah
    Memarnejadian, Arash
    Namdar, Afshin
    Khamisabadi, Masoumeh
    Sadat, Seyed Mehdi
    Asgarian-Omran, Hossein
    Azadmanesh, Kayhan
    Kokhaei, Parviz
    Aghasadeghi, Mohammad Reza
    Hadjati, Jamshid
    MEDICAL ONCOLOGY, 2011, 28 : S660 - S666
12345